Home | About Us | Management | Capabilities | CME Research | Outcomes | Contact Us
Log In | Register

  • Applying Oral Therapies to Improve Patient Outcomes in MS
  • Individualized Management in Rheumatoid Arthritis: Optimizing Biological Treatment
  • Applying Biologic Therapies to the Management of Patients with Rheumatoid Arthritis
  • Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients with Metastatic Breast Cancer
  • Oral Therapies for the Treatment of Multiple Sclerosis: Practical Solutions for Every Clinical Practice
  • Improving Patient Outcomes in Multiple Sclerosis: Clinical Trial Data and Management Strategies
Applying Oral Therapies to Improve Patient Outcomes in MS Individualized Management in Rheumatoid Arthritis: Optimizing Biological Treatment Applying Biologic Therapies to the Management of Patients with Rheumatoid Arthritis Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients with Metastatic Breast Cancer Oral Therapies for the Treatment of Multiple Sclerosis: Practical Solutions for Every Clinical Practice Improving Patient Outcomes in Multiple Sclerosis: Clinical Trial Data and Management Strategies
Gallery Slideshow by WOWSlider.com v4.7

Latest Activities


Applying Oral Therapies to Improve Patient Outcomes in Multiple Sclerosis Applying Oral Therapies to Improve Patient Outcomes in Multiple Sclerosis
1.00 AMA PRA Category 1 Credit(s) TM
Given the fast pace of clinical research, the array of available and emergent therapies to treat multiple sclerosis has grown. With the availability of new oral pharmacotherapies, alterations of the clinical decision-making process is increasingly important. A panel of expert physicians will address strategies to help clinicians monitor and manage long-term events, compliance, and subsequent switching of therapies based on individualized treatment plans. This CME activity enables learners to remain current on the clinical trial data of oral therapeutics and provides applicable information to clinical practice resulting in optimized care for patients with MS.

 

Individualized Management in Rheumatoid Arthritis: Optimizing Biological TreatmentIndividualized Management in Rheumatoid Arthritis: Optimizing Biological Treatment
1.00 AMA PRA Category 1 Credit(s) TM
A substantial proportion of the rheumatoid arthritis patient population is not only unresponsive to therapy but experiences an unsustained response to treatment. The management of RA actively evolves as further evidence-based data becomes available. This program is designed to improve the educational command of immunology science and how it is...

 

Applying Biologic Therapies to the Management of Patients with Rheumatoid ArthritisApplying Biologic Therapies to the Management of Patients with Rheumatoid Arthritis
1.00 AMA PRA Category 1 Credit(s) TM
The challenge of providing uniformly effective rheumatoid arthritis care has thus far defied a simple solution. Variations in care range from the appropriate adjustment or switching of therapy subsequent to increased disease activity to the selection of therapeutic agent chosen following failure. This program is designed to improve the...

 

Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients with Metastatic Breast CancerUtilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients with Metastatic Breast Cancer
1.00 AMA PRA Category 1 Credit(s) TM
Patients with advancing metastatic breast cancer present the most challenging management decisions for the practicing oncologist. Over recent years, newer data on microtubute dynamics inhibitor therapeutics have shown improved overall survival for patients previously treated with traditional first and second line chemotherapies. This CME program...

 

Oral Therapies for the Treatment of Multiple Sclerosis: Practical Solutions for Every Clinical PracticeOral Therapies for the Treatment of Multiple Sclerosis: Practical Solutions for Every Clinical Practice
1.00 AMA PRA Category 1 Credit(s) TM
At present, the field of multiple sclerosis (MS) research has made remarkable progress revealing innovative agents, both currently approved for treatment and emerging therapies. With the availability of three oral agents, clinical decision-making and therapeutic strategies are increasingly important. This unique webcast includes a panel of expert...


 

mproving Patient Outcomes in Multiple Sclerosis: Clinical Trial Data and Management StrategiesImproving Patient Outcomes in Multiple Sclerosis: Clinical Trial Data and Management Strategies
2.00 AMA PRA Category 1 Credit(s) TM
The ArcheMedX learning architecture offers participants interaction to achieve a deeper understanding of the content allowing the learner opportunities to sharpen their clinical skills.
Lesson 1: Recent Advances in Multiple Sclerosis Science

Lesson 2: An Update on Current Therapeutic Options
Lesson 3: Efficacy and Safety of Emerging Therapies
Lesson 4: Implementing Individualized Treatment Plans that Improve Patient Outcomes